Fort Collins biopharma company lands $20.3M defense contract
FORT COLLINS — A Fort Collins biopharma company has landed a $20.3 million federal contract to develop a wound-wash product that the Department of Defense and civil defense agencies can use to decontaminate chemical wounds.
Armis Biopharma Inc. received the contract from the Defense Threat Reduction Agency; the money will be used to further develop its proprietary Veriox DECON chemical warfare agent decontamination product for use in battlefield wounds.
“We’ve been working on this for quite a while,” said Ted Ziemann, chairman and CEO of Armis. “It’s important because, two things, with what’s happening in the world right now — developing…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Boulder’s Human Relations Fund, which supports community-initiated activities that focus on civil rights, human rights…
-
Voters in the southeastern Weld County town of Hudson were opposing Ballot Issue 2F, a…
-
Same-sex marriage has been legal nationwide for nearly a decade, but, thanks to a currently…
-
Downtown Boulder’s Business Improvement District is recruiting two at-large board members.
